These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31242818)

  • 1. CFH and CFB mutations in Shiga toxin-associated haemolytic uraemic syndrome in a 6-year-old boy.
    Çelakil ME; Yücel BB; Bek K
    Paediatr Int Child Health; 2020 May; 40(2):129-131. PubMed ID: 31242818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CFH gene mutation in a case of Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS).
    Caillaud C; Zaloszyc A; Licht C; Pichault V; Frémeaux-Bacchi V; Fischbach M
    Pediatr Nephrol; 2016 Jan; 31(1):157-61. PubMed ID: 26399238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome.
    Walsh PR; Johnson S
    Pediatr Nephrol; 2019 Sep; 34(9):1485-1492. PubMed ID: 30058046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome.
    Westra D; Volokhina EB; van der Molen RG; van der Velden TJ; Jeronimus-Klaasen A; Goertz J; Gracchi V; Dorresteijn EM; Bouts AH; Keijzer-Veen MG; van Wijk JA; Bakker JA; Roos A; van den Heuvel LP; van de Kar NC
    Pediatr Nephrol; 2017 Feb; 32(2):297-309. PubMed ID: 27718086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response to lipopolysaccharides and recombinant proteins of Shiga toxin (STX)-producing Escherichia coli (STEC) in children with haemolytic uraemic syndrome in Poland.
    Rastawicki W; Śmietańska K; Rokosz-Chudziak N; Wołkowicz T
    Lett Appl Microbiol; 2020 Jun; 70(6):440-446. PubMed ID: 32270510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Complement Factor B Gene Mutation Identified in a Kidney Transplant Recipient with a Shiga Toxin-Triggered Episode of Thrombotic Microangiopathy.
    Korzycka J; Pawłowicz-Szlarska E; Masajtis-Zagajewska A; Nowicki M
    Am J Case Rep; 2022 Oct; 23():e936565. PubMed ID: 36306276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HUS with mutations in CFH and STEC infection treated with eculizumab in a 4-year-old girl.
    Galvez C; Krall P; Rojas A; Oh J; Cano F
    Pediatr Nephrol; 2023 Apr; 38(4):1195-1203. PubMed ID: 35969277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of children with Shiga toxin-associated haemolytic uraemic syndrome treated with eculizumab: a matched cohort study.
    Monet-Didailler C; Chevallier A; Godron-Dubrasquet A; Allard L; Delmas Y; Contin-Bordes C; Brissaud O; Llanas B; Harambat J
    Nephrol Dial Transplant; 2020 Dec; 35(12):2147-2153. PubMed ID: 31411695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complement factor B mutation in atypical hemolytic uremic syndrome. Rare cause of rare disease].
    Visconti L; Cernaro V; Ardissino G; Sgarbanti M; Ferrara D; Visconti G; Santoro D; Buemi M
    G Ital Nefrol; 2017 Apr; 34(2):74-81. PubMed ID: 28682564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview.
    Kakoullis L; Papachristodoulou E; Chra P; Panos G
    J Infect; 2019 Aug; 79(2):75-94. PubMed ID: 31150744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations.
    Alberti M; Valoti E; Piras R; Bresin E; Galbusera M; Tripodo C; Thaiss F; Remuzzi G; Noris M
    Am J Transplant; 2013 Aug; 13(8):2201-6. PubMed ID: 23731345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement Gene Variants and Shiga Toxin-Producing
    Frémeaux-Bacchi V; Sellier-Leclerc AL; Vieira-Martins P; Limou S; Kwon T; Lahoche A; Novo R; Llanas B; Nobili F; Roussey G; Cailliez M; Ulinski T; Deschênes G; Alberti C; Weill FX; Mariani P; Loirat C
    Clin J Am Soc Nephrol; 2019 Mar; 14(3):364-377. PubMed ID: 30674459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemolytic uraemic syndrome associated with non shiga toxin-producing Escherichia coli bacteraemia: a case report.
    Bally S; Fourcade J; Frémeaux-Bacchi V
    BMC Nephrol; 2019 May; 20(1):157. PubMed ID: 31064333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ockham's razor defeated: about two atypical cases of hemolytic uremic syndrome.
    Schwarz C; Brehon A; Mousseaux C; Luque Y; Senet P; Mariani P; Mohamadou I; Zafrani L; Frémeaux-Bacchi V; Rondeau E; Buob D; Rafat C
    BMC Nephrol; 2020 Jul; 21(1):269. PubMed ID: 32652955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased severity of Shiga toxin-producing
    Geramita MA; Hofer J; Cooper J; Moritz ML
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28855217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
    Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Where are we with haemolytic uremic syndrome?
    Cavero T; Alonso M
    Med Clin (Barc); 2018 Oct; 151(8):329-335. PubMed ID: 29699703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and management of children with haemolytic uraemic syndrome.
    Walsh PR; Johnson S
    Arch Dis Child; 2018 Mar; 103(3):285-291. PubMed ID: 28899876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atypical HUS caused by complement-related abnormalities].
    Yoshida Y; Matsumoto M
    Rinsho Ketsueki; 2015 Feb; 56(2):185-93. PubMed ID: 25765799
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.